{"id":3968,"date":"2021-03-01T16:02:47","date_gmt":"2021-03-01T15:02:47","guid":{"rendered":"https:\/\/www.echosens.com\/bibliography\/"},"modified":"2022-08-03T12:15:22","modified_gmt":"2022-08-03T10:15:22","slug":"bibliografia","status":"publish","type":"page","link":"https:\/\/www.echosens.com\/es\/bibliografia\/","title":{"rendered":"Bibliograf\u00eda"},"content":{"rendered":"
    \n
  1. European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-264. doi:10.1016\/j.jhep.2015.04.006.<\/li>\n
  2. Karlas T, Petroff D, Sasso M, et al. <\/em>Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022-1030. doi:10.1016\/j.jhep.2016.12.022.<\/li>\n
  3. Recio E, Cifuentes C, Mac\u00edas J, et al. <\/em>Interobserver concordance in controlled attenuation parameter measurement, a novel tool or the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Hepatol. 2013;25(8):905-911.doi:10.1097\/MEG.0b013e32835f4c3d.<\/li>\n
  4. Stefanescu H, Marasco G, Cal\u00e8s P, et al. <\/em>A novel spleen-dedicated stiffness measurement by FibroScan\u00ae<\/sup> improves the screening of high-risk oesophageal varices. Liver Int. 2020;40(1):175-185. doi:10.1111\/liv.14228.<\/li>\n
  5. Gin\u00e8s P, Graupera I, Lammert F, et al. Screening for liver fibrosis in the general population: a call for action. The Lancet Gastroenterology & Hepatology. 2016;1(3):256-260. doi:10.1016\/S2468-1253(16)30081-4.<\/li>\n<\/ol>\n
      \n
    1. Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38 Suppl 1:2-6. doi:10.1111\/liv.13682.<\/li>\n<\/ol>\n
        \n
      1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-171. doi:10.1016\/j.jhep.2018.09.014.<\/li>\n
      2. Wong VW-S, Adams LA, de L\u00e9dinghen V, Wong GL-H, Sookoian S. Noninvasive biomarkers in NAFLD and NASH – current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018;15(8):461-478. doi:10.1038\/s41575-018-0014-9.<\/li>\n<\/ol>\n
          \n
        1. Kwok R, Choi KC, Wong GL-H, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2016;65(8):1359-1368. doi:10.1136\/gutjnl-2015-309265.<\/li>\n<\/ol>\n
            \n
          1. Younossi ZM. The epidemiology of nonalcoholic steatohepatitis. Clin Liver Dis (Hoboken). 2018;11(4):92-94. doi:10.1002\/cld.710.<\/li>\n<\/ol>\n
              \n
            1. Seitz HK, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4(1):16. doi:10.1038\/s41572-018-0014-7.<\/li>\n<\/ol>\n
                \n
              1. WHO. Guidelines for the Screening Care and Treatment of Persons with Hepatitis C Infection. April 2014. http:\/\/public.ebookcentral<\/a>. proquest.com\/choice\/publicfullrecord.aspx?p=1975017. Accessed March 4, 2020.<\/li>\n<\/ol>\n
                  \n
                1. WHO. Hepatitis B. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed February 14, 2020.<\/li>\n
                2. WHO. Department of HIV\/AIDS, the Global Hepatitis Programme. World Hepatitis Day 2017, WHO guide on advocacy and communications. 2017. https:\/\/www.who.int\/campaigns\/hepatitis-day\/2017\/campaign-brief.pdf?ua=1<\/a><\/li>\n<\/ol>\n
                    \n
                  1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20. doi:10.1038\/nrgastro.2017.109.<\/li>\n<\/ol>\n
                      \n
                    1. Ahmad J, Lau. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. HMER. Published online February 2013:1. doi:10.2147\/HMER.S9049.<\/li>\n<\/ol>\n
                        \n
                      1. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease: Estes et al. Hepatology. 2018;67(1):123-133. doi:10.1002\/hep.29466.<\/li>\n
                      2. Ofusu 2018<\/li>\n
                      3. Friedman, 2018<\/li>\n
                      4. Lanthier, 2018<\/li>\n
                      5. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038\/ajg.2017.469 . Epub 2018 Jan 16. PMID: 29336434 ; PMCID: PMC6524956.<\/li>\n
                      6. Rehm, J. et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta- analysis. Drug Alcohol Rev.29, 437\u2013445 (2010).<\/li>\n
                      7. WHO. Hepatitis B. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed February 14, 2020.<\/li>\n
                      8. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016\/j.jhep.2017.03.021. Epub 2017 Apr 18. PMID: 28427875.<\/li>\n
                      9. Lim JK, Flamm SL, Singh S, Falck-Ytter YT; Clinical Guidelines Committee of the American Gastroenterological Association. American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology. 2017 May;152(6):1536-1543. doi: 10.1053\/j.gastro.2017.03.017. PMID: 28442119.<\/li>\n
                      10. Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver International 2009;29:1500-1506.<\/li>\n
                      11. Arena U, Lupsor Platon M, Stasi C, Moscarella S, Assarat A, Bedogni G, Piazzolla V, et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 2013;58:65-72.<\/li>\n
                      12. Berzigotti A, De Gottardi A, Vukotic R, Siramolpiwat S, Abraldes JG, Garcia-Pagan JC, Bosch J. Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS One 2013;8:e58742.<\/li>\n
                      13. Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013;57:1182-1191.<\/li>\n
                      14. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357. doi:10.1002\/hep.29367.<\/li>\n
                      15. Ferraioli G, Wong VW-S, Castera L, et al. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol. 2018;44(12):2419-2440. doi:10.1016\/j.ultrasmedbio.2018.07.008.<\/li>\n
                      16. Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11(1):1-30. doi:10.1007\/s12072-016-9760-3.<\/li>\n
                      17. Audi\u00e8re et al. EASL 2020 poster #FRI-073.<\/li>\n
                      18. Cohen JC, et al. Science. 2011;332(6037): 1519- 1523.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                        European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-264. doi:10.1016\/j.jhep.2015.04.006. Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022-1030. […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/modular.php","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"class_list":["post-3968","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nBibliograf\u00eda - Echosens<\/title>\n<meta name=\"description\" content=\"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.echosens.com\/es\/bibliografia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bibliograf\u00eda - Echosens\" \/>\n<meta property=\"og:description\" content=\"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.echosens.com\/es\/bibliografia\/\" \/>\n<meta property=\"og:site_name\" content=\"Echosens\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fibroscan.echosens\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-03T10:15:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Echosens\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.echosens.com\/es\/bibliografia\/\",\"url\":\"https:\/\/www.echosens.com\/es\/bibliografia\/\",\"name\":\"Bibliograf\u00eda - Echosens\",\"isPartOf\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#website\"},\"datePublished\":\"2021-03-01T15:02:47+00:00\",\"dateModified\":\"2022-08-03T10:15:22+00:00\",\"description\":\"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.echosens.com\/es\/bibliografia\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.echosens.com\/es\/bibliografia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.echosens.com\/es\/bibliografia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.echosens.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bibliograf\u00eda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.echosens.com\/es\/#website\",\"url\":\"https:\/\/www.echosens.com\/es\/\",\"name\":\"Echosens\",\"description\":\"Un site utilisant WordPress\",\"publisher\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.echosens.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.echosens.com\/es\/#organization\",\"name\":\"ECHOSENS\",\"url\":\"https:\/\/www.echosens.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"contentUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ECHOSENS\"},\"image\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fibroscan.echosens\",\"https:\/\/x.com\/Echosens\",\"https:\/\/www.linkedin.com\/company\/echosens\/\",\"https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bibliograf\u00eda - Echosens","description":"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.echosens.com\/es\/bibliografia\/","og_locale":"es_ES","og_type":"article","og_title":"Bibliograf\u00eda - Echosens","og_description":"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","og_url":"https:\/\/www.echosens.com\/es\/bibliografia\/","og_site_name":"Echosens","article_publisher":"https:\/\/www.facebook.com\/fibroscan.echosens","article_modified_time":"2022-08-03T10:15:22+00:00","twitter_card":"summary_large_image","twitter_site":"@Echosens","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.echosens.com\/es\/bibliografia\/","url":"https:\/\/www.echosens.com\/es\/bibliografia\/","name":"Bibliograf\u00eda - Echosens","isPartOf":{"@id":"https:\/\/www.echosens.com\/es\/#website"},"datePublished":"2021-03-01T15:02:47+00:00","dateModified":"2022-08-03T10:15:22+00:00","description":"Bibliograf\u00eda . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","breadcrumb":{"@id":"https:\/\/www.echosens.com\/es\/bibliografia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.echosens.com\/es\/bibliografia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.echosens.com\/es\/bibliografia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.echosens.com\/es\/"},{"@type":"ListItem","position":2,"name":"Bibliograf\u00eda"}]},{"@type":"WebSite","@id":"https:\/\/www.echosens.com\/es\/#website","url":"https:\/\/www.echosens.com\/es\/","name":"Echosens","description":"Un site utilisant WordPress","publisher":{"@id":"https:\/\/www.echosens.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.echosens.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.echosens.com\/es\/#organization","name":"ECHOSENS","url":"https:\/\/www.echosens.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","width":1,"height":1,"caption":"ECHOSENS"},"image":{"@id":"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fibroscan.echosens","https:\/\/x.com\/Echosens","https:\/\/www.linkedin.com\/company\/echosens\/","https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg"]}]}},"_links":{"self":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/3968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/comments?post=3968"}],"version-history":[{"count":4,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/3968\/revisions"}],"predecessor-version":[{"id":60795,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/3968\/revisions\/60795"}],"wp:attachment":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/media?parent=3968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}